Dimensional Fund Advisors’s Marker Therapeutics MRKR Stock Holding History

Dimensional Fund Advisors’s Portfolio MRKR Stock Details MRKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-15,900	Closed	-$24.3K	–	3319
2025 Q2	$24.3K	Hold	15,900	–	–	﹤0.01%	3265
2025 Q1	$19.6K	Hold	15,900	–	–	﹤0.01%	3305
2024 Q4	$49.4K	Sell	15,900 -4,378	-22%	-$15.5K	﹤0.01%	3293
2024 Q3	$57.2K	Hold	20,278	–	–	﹤0.01%	3287
2024 Q2	$110K	Hold	20,278	–	–	﹤0.01%	3240
2024 Q1	$87.2K	Hold	20,278	–	–	﹤0.01%	3272
2023 Q4	$112K	Hold	20,278	–	–	﹤0.01%	3266
2023 Q3	$93.3K	Buy	+20,278	New	+$113K	﹤0.01%	3324
2022 Q1	–	Sell	-6,505	Closed	-$62K	–	3538
2021 Q4	$62K	Sell	6,505 -8,336	-56%	-$111K	﹤0.01%	3474
2021 Q3	$251K	Buy	14,841 +8,006	+117%	+$164K	﹤0.01%	3310
2021 Q2	$191K	Buy	6,835 +1,273	+23%	+$33.5K	﹤0.01%	3343
2021 Q1	$125K	Hold	5,562	–	–	﹤0.01%	3331
2020 Q4	$81K	Hold	5,562	–	–	﹤0.01%	3288
2020 Q3	$83K	Buy	5,562 +580	+12%	+$10.6K	﹤0.01%	3277
2020 Q2	$103K	Buy	+4,982	New	+$109K	﹤0.01%	3275

Other funds holding MRKR

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

TGIA

Torrey Growth & Income Advisors Del Mar, California $239M AUM

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Dimensional Fund Advisors's MRKR Position: Q3 2025 in Review

Dimensional Fund Advisors sold out of Marker Therapeutics (MRKR) in Q3 2025, closing a stake of 15,900 shares — an estimated $24.3K sold.

Dimensional Fund Advisors first reported a position in MRKR in Q2 2020 and held it in 15 quarters. The position peaked at $251K in Q3 2021. 32 funds tracked by Wall St. Rank hold MRKR as of Q3 2025.

Dimensional Fund Advisors reported no remaining Marker Therapeutics position as of Q3 2025 after selling out during the quarter.
Dimensional Fund Advisors sold 15,900 Marker Therapeutics shares in Q3 2025, an estimated $24.3K.
Dimensional Fund Advisors first reported a position in Marker Therapeutics in Q2 2020 and held it in 15 quarters.
Dimensional Fund Advisors's Marker Therapeutics position peaked at $251K in Q3 2021.
32 funds tracked by Wall St. Rank held Marker Therapeutics as of Q3 2025.

Based on Dimensional Fund Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.